Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,844 | 23,576 | 4,706 | 5,051 | 16,642 |
| Receivables | 552 | 942 | 61 | 21 | 34 |
| Income taxes - deferred | N/A | N/A | 631 | 981 | N/A |
| Other current assets | 0 | 2,121 | 9,138 | 0 | 0 |
| TOTAL | $14,396 | $26,639 | $14,536 | $6,053 | $16,676 |
| Non-Current Assets | |||||
| PPE Net | 10 | 2 | 7 | 12 | 11 |
| Intangibles | N/A | 1 | 73 | 145 | 217 |
| Other Non-Current Assets | 0 | 0 | 1,374 | 0 | 0 |
| TOTAL | $10 | $3 | $1,454 | $157 | $228 |
| Total Assets | $14,406 | $26,642 | $15,990 | $6,210 | $16,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 340 | 1,335 | 723 | 1,035 | 1,771 |
| TOTAL | $559 | $1,973 | $1,073 | $2,027 | $2,502 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $559 | $1,973 | $1,073 | $2,027 | $2,502 |
| Shareholders' Equity | |||||
| Common Shares | 126,426 | 126,426 | 124,785 | 112,829 | 111,912 |
| Retained earnings | -104,076 | -93,260 | -100,062 | -98,354 | -89,746 |
| Other shareholders' equity | -8,503 | -8,497 | -9,806 | -20,951 | -7,764 |
| TOTAL | $13,847 | $24,669 | $14,917 | $-6,476 | $14,402 |
| Total Liabilities And Equity | $14,406 | $26,642 | $15,990 | $-4,449 | $16,904 |